Ratio Therapeutics and PharmaLogic News and Resources

Ratio Therapeutics, a developer of radiotherapeutics, has expanded its partnership with Florida-based contract development and manufacturing organisation (CDMO) PharmaLogic. This expansion comes on the heels of a $50 million series B financing round. The partnership aims to accelerate the development and